EU Consortia on Personalized Medicine in Heart Failure
Heart Failure 2025 Belgrade
The Heart Failure Congress is the world’s leading event covering the entire spectrum of heart failure. It is the annual meeting of the Heart Failure Association of the ESC, whose mission is to improve quality of life and longevity through better prevention, diagnosis, and treatment of heart failure, including the establishment of networks for its management, education, and research. The 2025 edition, taking place in Belgrade and online, will feature an extensive and didactic programme with the world’s leading faculty and Late-Breaking Science.
As part of this prestigious event, the BIOTOOL-CHF project will participate in its second project workshop. Dr. Igor Diemberger will present BIOTOOL-CHF with a talk titled: What are the current unmet needs for congestion assessment in chronic heart failure?
BIOTOOL-CHF 2nd Workshop Information
17-20 May 2025
In person and Online Workshop
Milentija Popovica 9, 11000 Belgrade, RS
Sava Centar Belgrade
Sava Center is located in New Belgrade, at Milentija Popovića Street 9, approximately 30 minutes from Nikola Tesla Airport and 15 minutes from the city centre.
Workshop Agenda
Introduction and overview of the projects
Time to be defined
STRATIFYHF: What is the optimal clinical study design to support the development and evaluation of AI-based risk assessment?
Time to be defined
Speaker: Professor Djordje Jakovljevic
BIOTOOL-CHF: What are the current unmet needs for congestion assessment in chronic heart failure?
Time to be defined
Speaker: Professor Igor Diemberger
AI4HF: Is the data driving AI algorithms for chronic heart failure risk assessment truly representative and unbiased?
Time to be defined
Speaker: Prof. Dr. Folkert W. Asselbergs
Q&A Session
Time to be defined
Clustering and Networking
Joining the BIOTOOL-CHF project in this workshop will be the AI4HF and STRATIFYHF projects, with which BIOTOOL-CHF has initiated Networking and Clustering activities.
The “Trustworthy Artificial Intelligence for Personalised Risk Assessment in Chronic Heart Failure (AI4HF)” project is an innovative initiative that harnesses the power of Artificial Intelligence (AI) to provide personalized risk assessment and care plans for individuals living with Chronic Heart Failure. It utilizes advanced AI algorithms, global collaboration, and a patient-centered approach to improve healthcare outcomes.
Artificial intelligence-based decision support system for risk stratification and early detection of heart failure in primary and secondary care. The overarching AIM of this Research and Innovation Action is to develop and clinically validate a truly innovative AI-based Decision Support System (STRATIFYHF) for predicting risk of HF, facilitating its early diagnosis and progression prediction that will radically change how HF is managed in both primary and secondary care.
Organized by
